Literature DB >> 2106752

Immunohistochemical differential diagnosis of granulocytic sarcomas and malignant lymphomas on formalin-fixed material.

C Fellbaum1, M L Hansmann.   

Abstract

A panel of monoclonal antibodies (anti-CD45 [common leukocyte antigen], Ki-B3, L26, MT1, UCHL1, anti-CD15 [X-hapten], anti-neutrophil granule protein elastase [NP57]), anti-lysozyme, and the naphthol-ASD-chloroacetate reaction were applied to two cases of granulocytic sarcoma (GS) for evaluation of their utility in differentiating GS from malignant lymphoma. Lysozyme and naphthol-ASD-chloroacetate esterase were found to be the most reliable markers for detection of the myeloid nature of the tumour cells. GS infiltrated solely the mucosa of the nasal cavity in one case, while in the other it involved both the nasal cavity and maxillary sinus with simultaneous eruptions on the skin of the trunk. In both cases, peripheral blood and bone marrow findings were inconspicuous at the time of diagnosis of GS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106752     DOI: 10.1007/bf01605296

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  24 in total

1.  [ON THE SELECTIVE ENZYME-CYTOCHEMICAL DEMONSTRATION OF NEUTROPHILIC MYELOID CELLS AND TISSUE MAST CELLS IN PARAFFIN SECTIONS].

Authors:  L D LEDER
Journal:  Klin Wochenschr       Date:  1964-06-01

2.  The demonstration of B-cell, T-cell and myeloid antigens in paraffin sections.

Authors:  K P West; A Warford; L Fray; M Allen; A C Campbell; I Lauder
Journal:  J Pathol       Date:  1986-10       Impact factor: 7.996

3.  Use of monoclonal antibody against human neutrophil elastase in normal and leukaemic myeloid cells.

Authors:  K A Pulford; W N Erber; J A Crick; I Olsson; K J Micklem; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

4.  Paraffin section immunohistochemistry. I. Non-Hodgkin's lymphoma.

Authors:  P A Hall; A J d'Ardenne; A G Stansfeld
Journal:  Histopathology       Date:  1988-08       Impact factor: 5.087

5.  Granulocytic sarcoma in nonleukemic patients.

Authors:  J M Meis; J J Butler; B M Osborne; J T Manning
Journal:  Cancer       Date:  1986-12-15       Impact factor: 6.860

6.  Chloroma (granulocytic sarcoma) without evidence of leukemia: facilitated light microscopic diagnosis.

Authors:  K S McCarty; J Wortman; J Daly; R W Rundles; J S Hanker
Journal:  Blood       Date:  1980-07       Impact factor: 22.113

7.  Diagnosis of acute myeloid leukaemia with the use of monoclonal anti-neutrophil elastase (NP57) reactive with routinely processed biopsy samples.

Authors:  E Ralfkiaer; K A Pulford; A F Lauritzen; S Avnstrøm; B Guldhammer; D Y Mason
Journal:  Histopathology       Date:  1989-06       Impact factor: 5.087

8.  Granulocytic sarcoma of the hard palate: report of the first case.

Authors:  A Castella; F R Davey; A Elbadawi; G B Gordon
Journal:  Hum Pathol       Date:  1984-12       Impact factor: 3.466

9.  Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases.

Authors:  R S Neiman; M Barcos; C Berard; H Bonner; R Mann; R E Rydell; J M Bennett
Journal:  Cancer       Date:  1981-09-15       Impact factor: 6.860

10.  The immunophenotyping of extramedullary myeloid cell tumors in paraffin-embedded tissue sections.

Authors:  F R Davey; S Olson; A S Kurec; R Eastman-Abaya; A J Gottlieb; D Y Mason
Journal:  Am J Surg Pathol       Date:  1988-09       Impact factor: 6.394

View more
  3 in total

1.  Primary granulocytic sarcoma of the face.

Authors:  Jong Ik Hwang; Tae Yoon Kim
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

2.  Maxillo-ethmoidal chloroma in acute myeloid leukaemia: case report.

Authors:  E Ferri; C Minotto; F Ianniello; S Cavaleri; E Armato; P Capuzzo
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

3.  Cerebrospinal fluid cytology in granulocytic sarcoma with meningeal extension but without bone marrow involvement.

Authors:  E Sindern; F Burghardt; R Voigtmann; J P Malin
Journal:  J Neurol       Date:  1994-03       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.